Transcatheter Aortic Valve Implantation and Four-Year Follow Up in a 99-Year-Old Patient

Jabs A., KILIÇ T., Schnelle N., Post F., Vosseler M., Vahl C., ...Daha Fazla

JOURNAL OF HEART VALVE DISEASE, cilt.22, sa.2, ss.261-264, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 2
  • Basım Tarihi: 2013
  • Dergi Adı: JOURNAL OF HEART VALVE DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.261-264
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Transcatheter aortic valve implantation (TAVI) has emerged as a life-saving therapy in patients with severe aortic valve stenosis who are considered to be high-risk surgical candidates. However, there is a paucity of data on the long-term survival and quality-of-life in very old patients undergoing TAVI. Here, the case is reported of a now 104-year-old patient who underwent percutaneous transfemoral TAVI with a CoreValve (TM) prosthesis at the age of 99 years; details of his four-year outcome data are also provided. To best of the authors' knowledge, this patient is the oldest reported to have undergone TAVI, and is currently living with good functional status more than four years after the intervention.